Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Gains from Sales and Divestitures (2016 - 2021)

Historic Gains from Sales and Divestitures for Orthofix Medical (OFIX) over the last 11 years, with Q4 2021 value amounting to $86542.0.

  • Orthofix Medical's Gains from Sales and Divestitures rose 1689.18% to $86542.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $86542.0, marking a year-over-year increase of 1689.18%. This contributed to the annual value of $86542.0 for FY2021, which is 1689.18% up from last year.
  • Orthofix Medical's Gains from Sales and Divestitures amounted to $86542.0 in Q4 2021, which was up 1689.18% from $74036.0 recorded in Q4 2020.
  • In the past 5 years, Orthofix Medical's Gains from Sales and Divestitures ranged from a high of $157807.0 in Q4 2017 and a low of $27982.0 during Q4 2018
  • Over the past 5 years, Orthofix Medical's median Gains from Sales and Divestitures value was $74036.0 (recorded in 2020), while the average stood at $78688.8.
  • Per our database at Business Quant, Orthofix Medical's Gains from Sales and Divestitures plummeted by 8226.82% in 2018 and then skyrocketed by 6824.03% in 2019.
  • Over the past 5 years, Orthofix Medical's Gains from Sales and Divestitures (Quarter) stood at $157807.0 in 2017, then plummeted by 82.27% to $27982.0 in 2018, then skyrocketed by 68.24% to $47077.0 in 2019, then soared by 57.27% to $74036.0 in 2020, then grew by 16.89% to $86542.0 in 2021.
  • Its Gains from Sales and Divestitures was $86542.0 in Q4 2021, compared to $74036.0 in Q4 2020 and $47077.0 in Q4 2019.